Mycophenolate Mofetil
Back to searchMolecule Structure
Scientific Name
Mycophenolate Mofetil
Description of the Drug
Mycophenolate mofetil is an inosine monophosphate dehydrogenase inhibitor used to prevent the rejection of kidney, heart, or liver transplants.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00688
http://www.drugbank.ca/drugs/DB00688
Brand Name(s)
Arzip, Cellcept, Mycophenolate mofetil, Myfenax
Company Owner(s)
Roche Palo Alto Llc, Alkem Laboratories Ltd, Mylan Pharmaceuticals Inc, Amneal Eu Ltd, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Akorn Operating Co Llc, Apotex Corp, Teva Pharmaceuticals Usa Inc, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Inosine-5′-monophosphate dehydrogenase (IMPDH) | PROTEIN FAMILY | INHIBITOR | CHEMBL2111369 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4195 | ||
| PharmGKB | PA450566 | ||
| Human Metabolome Database | HMDB0014826 | ||
| DrugBank | DB00688 | ||
| PubChem: Thomson Pharma | 14758955 | ||
| PubChem | 5281078 | ||
| LINCS | LSM-43041 | ||
| Nikkaji | J378.713C | ||
| BindingDB | 50248299 | ||
| EPA CompTox Dashboard | DTXSID3023340 | ||
| DrugCentral | 1859 | ||
| Brenda | 13198 | 161549 | |
| ChemicalBook | CB2663335 | CB5663336 | |
| Guide to Pharmacology | 6831 | ||
| rxnorm | CELLCEPT | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | MYCOPHENOLATE MOFETIL |
| PubChem: Drugs of the Future | 12014254 | ||
| KEGG Ligand | C07908 | ||
| ChEBI | 8764 | ||
| ZINC | ZINC000021297660 |
